ArticleJournal for immunotherapy of cancer2026

Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy.

Lyna Haybout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.